// App-Quantinova.ai

16349 2014 AHA : A Novel Class of Inhibitors That Are Specific to Human NPP1 Prevent Pathologic Mineralization of Valve Interstitial Cells

Researchers

Presenter

  • Elsa Forcellini

Principal Investigators

  • Marie-Chloe Boulanger

  • IUCPQ

  • Mahmut Ablajan

  • Sebastien Dautrey

  • Xavier Barbeau

  • Patrick Lague

  • Jean Sevigny

  • Jean-Francois Paquin

  • Patrick Mathieu

Medical Centers

  • Laval University, Quebec, Quebec, Canada.

  • CHUL, Quebec, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Calcific Aortic Valve Disease

Biomarkers

  • Alkaline phosphatase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved